Pfizer CEO Profits After COVID Vaccine Announcement

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Engineering
Scaling Experiential Learning in the Curriculum: How Iron Range Engineering Transformed Engineering Education
June 1, 2026

Engineering has transformed nearly every part of modern life, from the phones in our pockets to the systems powering global industry. But the way engineers are educated has often moved far more slowly than the profession itself. Employers are asking for graduates who can navigate ambiguity, communicate across teams, and contribute meaningfully from the…

Read More
vascular surgeon
When Geography Meets Purpose: How One Move Reshaped a Vascular Surgeon’s Career
May 28, 2026

Medicine isn’t what it used to be—not for the people practicing it. Independent physicians are becoming the exception, not the norm, as more doctors move into hospital systems, corporate groups, and academic networks. At the same time, the pipeline of specialists isn’t keeping pace with growing patient needs, particularly in complex fields like vascular…

Read More
safer HVAC chemicals
From Second Chances to Stronger Teams: Bradley Henderson on Structure, Culture, and Trades-Based Redemption
May 26, 2026

The trades have always demanded grit, but grit alone doesn’t build a strong workforce. People need structure, clear expectations, and a sense that their work is taking them somewhere. That’s especially true in HVAC and mechanical services, where employers are trying to hire, retain, and develop talent in a labor market that feels tighter and…

Read More
courage
Creative Confidence and Moral Courage: The Leadership Traits Business Schools Should Be Betting On
May 25, 2026

What students need from higher education is becoming harder to pin down than it once was. As higher education faces mounting pressure—from student disengagement to the rapid rise of artificial intelligence—institutions are being forced to rethink not just what students learn, but who they become. New research and industry signals suggest that technical knowledge…

Read More